We show that the recombinant C2IN-p53 fusion protein displays specific DNA-binding activity in vitro and demonstrate the C2IIa-dependent uptake of C2IN-p53 into the cytosol of diverse cancer cell lines such as HeLa cervix carcinoma and A549 lung adenocarcinoma cells. The gene discussed is TP53; the disease is cervical carcinoma.